cbdMD (YCBD) Net Equity Issued and Repurchased (2017 - 2024)

cbdMD (YCBD) has 7 years of Net Equity Issued and Repurchased data on file, last reported at $1.0 in Q3 2024.

• For the quarter ending Q3 2024, Net Equity Issued and Repurchased fell 99.98% year-over-year to $1.0; the trailing twelve-month figure through Sep 2025 stood at $1.0 (down 100.0% YoY), and the FY2024 full-year result was $50001.0, down 97.98% from the prior year.
• Net Equity Issued and Repurchased slipped to $1.0 in Q3 2024, from $4253.0 in the prior quarter.
• In the past five years, Net Equity Issued and Repurchased ranged from a high of $22.3 million in Q1 2021 to a low of -$2.2 million in Q3 2020.
• A 4-year average of $5.6 million and a median of $4253.0 in 2023 frame the typical range for Net Equity Issued and Repurchased.
• Across the five-year window, Net Equity Issued and Repurchased soared 32.96% in 2021 and plunged 99.98% in 2024, its largest moves.
• Tracing YCBD's Net Equity Issued and Repurchased over 4 years: stood at -$242744.0 in 2020, then jumped by 9286.63% to $22.3 million in 2021, then tumbled by 99.98% to $4253.0 in 2023, then sank by 99.98% to $1.0 in 2024.
• Business Quant data shows YCBD's Net Equity Issued and Repurchased at $1.0 in Q3 2024, $4253.0 in Q3 2023, and $2.5 million in Q2 2023.